Blood plasma metabolites and the risk of developing lung cancer in Russia

European Journal of Cancer Prevention

Volumn 22, Issue 4, 2013, Pages 335-341

  Lokhov, Petr G ^a   Trifonova, Oxana P ^a   Maslov, Dmitry L ^a   Archakov, Alexander I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

blood plasma; mass spectrometry; metabolomics; odds ratio; risk of lung cancer

Indexed keywords

METHANOL; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; PLASMA; PRIORITY JOURNAL; RUSSIAN FEDERATION;

ADULT; AGED; BENZENE; BIOTIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; PERMETHRIN; RISK; RUSSIA; SULFONES;

EID: 84878828420     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32835b3898     Document Type: Article

References (42)

1. Abass K, Reponen P, Turpeinen M, Jalonen J, Pelkonen O (2007). Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes. Drug Metab Dispos 35:1634-1641.
2. Benowitz NL (1999). Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 107 (Suppl 2):349-355.
3. Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A (2006). Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 15:1184-1188.
4. Carrola J, Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Carreira IM, et al. (2011). Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10:221-230.
5. Cheng LL, Burns MA, Taylor JL, He W, Halpern EF, McDougal WS, et al. (2005). Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 65:3030-3034.
6. Coyle YM, Minahjuddin AT, Hynan LS, Minna JD (2006). An ecological study of the association of metal air pollutants with lung cancer incidence in Texas. J Thorac Oncol 1:654-661.
7. Cutler DM (2008). Are we finally winning the war on cancer? J Econ Perspect 22:3-26.
8. Dettmer K, Aronov PA, Hammock BD (2007). Mass spectrometry-based metabolomics. Mass Spectrom Rev 26:51-78.
9. Dong J, Cai X, Zhao L, Xue X, Zou L, Zhang X, et al. (2010). Lysophosphatidylcholine profiling of plasma: discrimination of isomers and discovery of lung cancer biomarkers. Metabolomics 6:478-488.
10. Fritz A, Jack A, Parkin DM, Percy C, Shanmugarathan S, Sobin L, et al. (2000). International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: WHO.
11. Gallus S, Negri E, Boffetta P, McLaughlin JK, Bosetti C, La Vecchia C (2008). European studies on long-term exposure to ambient particulate matter and lung cancer. Eur J Cancer Prev 17:191-194.
12. Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D (2008). Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 8:617-633.
13. Hong WK, Tsao AS (2007). Lung carcinoma: tumors of the lungs. Merck Manual Professional Edition. Whitehouse Station, NJ, USA: Merck Sharp & Dohme Corp.
14. Hori S, Nishiumi S, Kobayashi K, Shinohara M, Hatakeyama Y, Kotani Y, et al. (2011). A metabolomic approach to lung cancer. Lung Cancer 74: 284-292.
15. IARC (1991). IARC monographs on the evaluation of carcinogenic risks to humans. Occupational exposures in insecticide application and some pesticides. vol. 53: Lyon, France: IARC.
16. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
17. Jordan KW, Adkins CB, Su L, Halpern EF, Mark EJ, Christiani DC, et al. (2010). Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs. Lung Cancer 68: 44-50.
18. Kabir Z, Bennett K, Clancy L (2007). Lung cancer and urban air-pollution in Dublin: a temporal association? Ir Med J 100:367-369.
19. Lang DH, Rettie AE, Bocker RH (1997). Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem Res Toxicol 10:1037-1044.
20. Lokhov PG, Dashtiev MI, Bondartsov LV, Lisitsa AV, Moshkovskii SA, Archakov AI (2009). Metabolic fingerprinting of blood plasma for patients with prostate cancer. Biomed Khim 55:247-254.
21. Lokhov PG, Dashtiev MI, Moshkovskii SA, Archakov AI (2010). Metabolite profiling of blood plasma of patients with prostate cancer. Metabolomics 6:156-163.
22. Lokhov PG, Kharybin ON, Archakov AI (2012). Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites. Int J Mass Spectrom 309:200-205.
23. Maeda Y, Segawa Y, Takigawa N, Takata I, Fujimoto N (1996). Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer. Intern Med 35:764-771.
24. Mock DM, Henrich CL, Carnell N, Mock NI (2002). Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge. Am J Clin Nutr 76:1061-1068.
25. Mutch E, Williams FM (2006). Diazinon chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology 224:22-32.
26. Mutch E, Daly AK, Leathart JB, Blain PG, Williams FM (2003). Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man? Arch Toxicol 77:313-320.
27. No authors listed (1992). Tobacco and cancer. Eur J Cancer Prev 1:211-213.
28. Nomeir AA, Abou-Donia MB (1983). High-performance liquid chromatographic analysis on radial compression column of the neurotoxic tri-o-cresyl phosphate and metabolites. Anal Biochem 135:296-303.
29. Osl M, Dreiseitl S, Pfeifer B,Weinberger K, Klocker H, Bartsch G, et al. (2008). A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry. Bioinformatics 24:2908-2914.
30. Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, et al. (2009). Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 4:669-673.
31. Ruano-Ravina A, Figueiras A, Montes-Martinez A, Barros-Dios JM (2003). Doseresponse relationship between tobacco and lung cancer: new findings. Eur J Cancer Prev 12:257-263.
32. Rusiecki JA, Patel R, Koutros S, Beane-Freeman L, Landgren O, Bonner MR, et al. (2009). Cancer incidence among pesticide applicators exposed to permethrin in the agricultural health study. Environ Health Perspect 117:581-586.
33. Schulz-Jander DA, Casida JE (2002). Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reduction. Toxicol Lett 132:65-70.
34. Sealey WM, Teague AM, Stratton SL, Mock DM (2004). Smoking accelerates biotin catabolism in women. Am J Clin Nutr 80:932-935.
35. Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, et al. (2005). METLIN: a metabolite mass spectral database. Ther Drug Monit 27:747-751.
36. Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, et al. (1999). Pro-gastrin-releasing peptide (ProGRP) - a useful marker in small cell lung carcinomas. Anticancer Res 19:2673-2678.
37. Tang J, Cao Y, Rose RL, Hodgson E (2002). In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem Biol Interact 141:229-241.
38. Thelestam M, Curvall M, Enzell CR (1980). Effect of tobacco smoke compounds on the plasma membrane of cultured human lung fibroblasts. Toxicology 15:203-217.
39. Van Vleet TR, Bombick DW, Coulombe RA Jr. (2001). Inhibition of human cytochrome P450 2E1 by nicotine, cotinine, and aqueous cigarette tar extract in vitro. Toxicol Sci 64:185-191.
40. Wang C, Yang J, Gao P, Lu X, Xu G (2005). Identification of phospholipid structures in human blood by direct-injection quadrupole-linear ion-trap mass spectrometry. Rapid Commun Mass Spectrom 19:2443-2453.
41. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. (2007). HMDB: the human metabolome database. Nucleic Acids Res 35:D521-D526.
42. Xue R, Lin Z, Deng C, Dong L, Liu T,Wang J, et al. (2008). A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 22:3061-3068.